| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/25/1997 | US5606023 Reduced toxicity |
| 02/25/1997 | US5606022 Cloning and identification of a two component signal transducing regulatory system from Bacteroides fragilis |
| 02/25/1997 | US5606021 Mineralocorticoid receptor compositions and methods |
| 02/25/1997 | US5606020 6 (R)-l-erythro-5,6,7,8-tetrahydrobiopterin receptor |
| 02/25/1997 | US5606019 Synthetic proteins having alternating blocks of fibroin and elastin repeating units; bioresorbable |
| 02/25/1997 | US5606017 Antitumor agents |
| 02/25/1997 | US5605887 Therapeutic fibrinogen compositions |
| 02/25/1997 | US5605886 Anti-obesity proteins |
| 02/25/1997 | US5605884 Mixture with sodium or potassium chloride, calcium chloride and histidine buffer |
| 02/25/1997 | US5605832 Dye transfer inhibition |
| 02/25/1997 | US5605831 Human melanoma cell specific antigens and antibodies |
| 02/25/1997 | US5605830 Cancer diagnosis, therapy |
| 02/25/1997 | US5605829 Synthetic proteoglycan having ovalbumin core protein linked to heparan sulfate, chondroitin sulfate, dermatan sulfate or combination thereof; promotes differentiation, maintains self-renewal capacity of cultured hematopoietic cells |
| 02/25/1997 | US5605827 Infectious bursal disease virus VP2 fusion protein expressed by baculovirus |
| 02/25/1997 | US5605822 Culturing human stem cells in liquid culture medium in the presence of transformed stromal cells |
| 02/25/1997 | US5605821 Expression control sequences of the P-selectin gene |
| 02/25/1997 | US5605817 DNA encoding chemokine expressed in fetal spleen |
| 02/25/1997 | US5605816 Transforming eukaryotic cell with vector; expression; cultures |
| 02/25/1997 | US5605815 Useful in detection of cancers |
| 02/25/1997 | US5605814 DNA encoding human prostaglandin receptor EP2 |
| 02/25/1997 | US5605811 Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein |
| 02/25/1997 | US5605809 Reagents comprising characteristically folded peptide backbone each end of which is conjugated to a fluorophore |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605803 Human sperm diagnostic |
| 02/25/1997 | US5605802 Method for identifying agents which block infection of cells by HIV |
| 02/25/1997 | US5605799 Somatic mutations in neurofibromatosis type 1 gene in human tumors |
| 02/25/1997 | US5605793 Adding to cleaved random double stranded fragments one or more single stranded or double stranded oligonucleotides, denaturing into single stranded fragments, incubating |
| 02/25/1997 | US5605792 Genetic engineering |
| 02/25/1997 | US5605791 Carbohydrate-directed cross-linking reagents |
| 02/25/1997 | US5605692 Polypeptide |
| 02/25/1997 | US5605691 Immunologically active proteins from inclusion bodies |
| 02/25/1997 | US5605690 Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor |
| 02/25/1997 | US5605689 Treatment of HIV-associated immune thrombocytopenic purpura |
| 02/25/1997 | US5605688 Recombinant dog and horse type I interferons |
| 02/25/1997 | CA2184046A1 Pharmaceutical compositions containing a neutralized virus and use thereof |
| 02/25/1997 | CA2110916C Reagents and methods for the quantification of imipramine or disipramine in biological fluids |
| 02/25/1997 | CA2078805C Cytokine preparation |
| 02/25/1997 | CA2077991C Cosmetics and pharmaceuticals containing extensins and related methods |
| 02/23/1997 | CA2183606A1 Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use |
| 02/20/1997 | WO1997006272A2 High efficiency helper system for aav vector production |
| 02/20/1997 | WO1997006270A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
| 02/20/1997 | WO1997006269A1 Inducible herbicide resistance |
| 02/20/1997 | WO1997006264A1 Bacterial peptide library |
| 02/20/1997 | WO1997006263A1 Hybrid protein comprising t-helper cell stimulating epitopes and b-cell epitopes from the major outer membrane protein of chlamydia trachomatis and its use as a vaccine |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997006259A2 Resistance against wilt inducing fungi |
| 02/20/1997 | WO1997006258A2 cDNA SEQUENCE, AMINO-ACID SEQUENCE, DERIVED FROM THE cDNA SEQUENCE, OF THE PRECURSOR PROTEIN OF HUMAN GCAP-II/UROGUANYLINE, AND AMINO-ACID SEQUENCE OF THE FRAGMENT CIRCULATING IN HUMAN BLOOD |
| 02/20/1997 | WO1997006257A1 Cellular co-factor for hiv rev and htlv rex |
| 02/20/1997 | WO1997006256A2 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006254A1 Human mp52 arg protein |
| 02/20/1997 | WO1997006251A1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-α RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-α AND ITS ANALOGUES |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997006241A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | WO1997006182A1 Inhibitors of apoptosis |
| 02/20/1997 | WO1997006176A2 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 02/20/1997 | WO1997005900A1 Cell derived antigen presenting vesicles |
| 02/20/1997 | WO1997005893A1 Remedy for ophthalmic diseases |
| 02/20/1997 | WO1997005886A1 Compositions for conferring immunogenicity to a peptide |
| 02/20/1997 | WO1997005885A1 Method of obtaining a molecular soluble keratin 'keratan' |
| 02/20/1997 | WO1997002730A3 Enamel matrix related polypeptide |
| 02/20/1997 | WO1996039512A3 A cell line for the rapid expression of functional calcium channels |
| 02/20/1997 | WO1996038571A3 Recombinant polypeptide cytotoxins for cancer treatment |
| 02/20/1997 | WO1996036711A3 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression |
| 02/20/1997 | WO1996031531A3 Fluorescent peptides |
| 02/20/1997 | WO1996027005A3 Recombinant dna molecules that code for polypeptides with antigenic properties of allergens clah8 and clah12 |
| 02/20/1997 | DE19540105C1 Compsn. contg. synthetic peptide(s) reactive with hepatitis C related antibodies |
| 02/20/1997 | CA2512366A1 Mammalian iap gene family, primers, probes and detection methods |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2228999A1 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis |
| 02/20/1997 | CA2228522A1 Hybrid protein comprising t-helper cell stimulating epitopes and b-cell epitopes from the major outer membrane protein of chlamydia trachomatis and its use as a vaccine |
| 02/20/1997 | CA2228512A1 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 02/20/1997 | CA2227584A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | CA2227524A1 Resistance against wilt inducing fungi |
| 02/20/1997 | CA2227204A1 Human mp52 arg protein |
| 02/20/1997 | CA2225553A1 Cell derived antigen presenting vesicles |
| 02/20/1997 | CA2224732A1 Inducible herbicide resistance |
| 02/20/1997 | CA2202131A1 Therapeutic agent for ophthalmic diseases |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758682A2 Hepatocyte growth factor activator inhibitor |
| 02/19/1997 | EP0758681A2 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 02/19/1997 | EP0758655A1 Process for the inactivation of carboxypeptidase Y in hirudin-containing culture broth |
| 02/19/1997 | EP0758401A1 Dry prothrombin time assay |
| 02/19/1997 | EP0758397A1 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 02/19/1997 | EP0758396A1 Feline immunodeficiency virus vaccine |
| 02/19/1997 | EP0758394A1 Bifunctional protein, preparation and use |
| 02/19/1997 | EP0758393A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils |
| 02/19/1997 | EP0758390A1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/19/1997 | EP0758386A1 Novel enzymatic rna molecules |
| 02/19/1997 | EP0758385A1 Chimeric delta-endotoxin expression in pseudomonas fluorescens |
| 02/19/1997 | EP0758384A1 Leishmania major protein, nucleic acid coding therefor, and uses thereof |
| 02/19/1997 | EP0758383A1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 02/19/1997 | EP0758382A1 Enhancing the sensitivity of tumor cells to therapies |
| 02/19/1997 | EP0758381A1 Biologically active eph family ligands |
| 02/19/1997 | EP0758376A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 02/19/1997 | EP0758342A1 New peptide active substance and production thereof |
| 02/19/1997 | EP0758341A1 FACTOR Xa INHIBITORS |
| 02/19/1997 | EP0758226A1 Red blood cell surrogate |
| 02/19/1997 | EP0758196A1 Compositions and methods of treating tumors |
| 02/19/1997 | EP0491878B1 Compositions for the inhibition of protein hormone formation and uses thereof |